FDA Requests Boxed Warnings on Older Class of Antipsychotic Drugs
The U.S. Food and Drug Administration has just released a requirement for manufacturers of the older class of antipsychotic drugs to make changes to their labeling. According to the FDA, these manufacturers need to warn consumers about the increased risk of death associated with using these drugs to treat behavioral problems in the elderly. Click here to read more on injuryboard.com
DIAL 1-800-ATTORNEY (1-800-288-6763) NATIONWIDE - ONE NUMBER - ONE CALL - ONE WEBSITE
Copyright 1998 - 2008, The Rasansky Law Firm | Principal Office: Dallas, TX | Disclaimer
2525 McKinnon St - Dallas, Texas 75201
For technical questions or to report an error with this site, click here to contact the site administrator
Add this page to social bookmark
